Patent details

Basic Information

Publication number:

EP2803350

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141793901

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

French Title of Invention:

Formulations pour voie orale d'ester de testosterone et methodes de traitement de carence en testosterone les comprenant

German Title of Invention:

Orale testosteronesterformulierungen und verfahren zur behandlung von testosteronmangel damit

SPC Number:

Dates

Filing date:

12/04/2010

Grant date:

20/09/2017

EP Publication Date:

19/11/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/09/2017

EP B1 Publication Date:

20/09/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/04/2018

Expiration date:

12/04/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/09/2017

 

 

Name:

Clarus Therapeutics, Inc.

Address:

555 Skokie Boulevard, Suite 340, Northbrook, IL 60062, United States (US)

Inventor

1

Name:

Dudley, Robert, E.

Address:

United States (US)

2

Name:

Constantinides, Panayiotis, P.

Address:

United States (US)

Classification

IPC classification:

A61K 9/107; A61K 9/48; A61K 31/568; A61K 47/12; A61K 47/14; A61K 47/44;

Publication

European Patent Bulletin

Issue number:

201738

Publication date:

20/09/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/08/2018	Outgoing Correspondence	1